Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?

Kyverna Therapeutics Ownership Summary

Kyverna Therapeutics is owned by 52.17% institutional investors, 11.88% insiders, and 35.96% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 10.47% of KYTX shares.

KYTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Kyverna Therapeutics	52.17%	11.88%	35.96%
Sector	Healthcare Stocks	42.64%	10.86%	46.50%
Industry	Biotech Stocks	45.45%	10.77%	43.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vida ventures advisors	4.52M	10.47%	$27.14M
Gilead sciences	4.13M	9.55%	$24.76M
Bain capital life sciences investors	3.37M	7.79%	$20.21M
Vanguard group	1.78M	4.10%	$16.74M
Price t rowe associates inc /md/	1.51M	3.50%	$9.07M
Aigh capital management	1.50M	3.46%	$14.10M
Insight group	989.05K	2.29%	$5.93M
Franklin resources	677.59K	1.57%	$4.07M
Mbb public markets i	614.48K	1.42%	$3.69M
Catalio capital management, lp	586.91K	1.36%	$3.52M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vida ventures advisors	4.52M	92.41%	$27.14M
Aigh capital management	1.50M	3.41%	$14.10M
Peapod lane capital	183.82K	1.47%	$1.73M
Gilead sciences	4.13M	1.38%	$24.76M
Bain capital life sciences investors	3.37M	1.34%	$20.21M
Catalio capital management, lp	586.91K	0.65%	$3.52M
Caxton	22.98K	0.60%	$137.89K
Mbb public markets i	614.48K	0.49%	$3.69M
Kera capital partners	421.92K	0.38%	$2.53M
Insight group	989.05K	0.37%	$5.93M

Top Buyers

Holder	Shares	% Assets	Change
Aigh capital management	1.50M	3.41%	1.50M
Vanguard group	1.78M	0.00%	458.63K
Rfg advisory	445.20K	0.08%	445.20K
Woodline partners lp	252.21K	0.01%	252.21K
Simplify asset management	192.34K	0.03%	192.34K

Top Sellers

Holder	Shares	% Assets	Change
Novo	-	-	-1.85M
Integral health asset management	-	-	-350.00K
Price t rowe associates inc /md/	1.51M	0.00%	-318.30K
Rock springs capital management lp	-	-	-178.96K
Superstring capital management lp	-	-	-142.54K

New Positions

Holder	Shares	% Assets	Change	Value
Aigh capital management	1.50M	3.41%	1.50M	$14.10M
Rfg advisory	445.20K	0.08%	445.20K	$4.18M
Woodline partners lp	252.21K	0.01%	252.21K	$1.51M
Simplify asset management	192.34K	0.03%	192.34K	$1.81M
American century companies	32.20K	0.00%	32.20K	$193.23K

Sold Out

Holder	Change
Ifp advisors	-16.00
Rothschild investment	-50.00
Jones financial companies lllp	-81.00
Sterling capital management	-186.00
Raymond james financial	-189.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	76	1.33%	22,548,873	0.47%	52	1.94%	30	-26.83%	26	8.33%
Jun 30, 2025	79	-10.23%	23,198,522	-10.03%	53	1.51%	44	4.76%	24	-4.00%
Mar 31, 2025	88	-1.12%	25,809,724	-9.40%	59	1.37%	41	-26.79%	25	92.31%
Dec 31, 2024	90	-4.26%	28,867,980	2.72%	66	1.58%	57	11.76%	13	-38.10%
Sep 30, 2024	94	4.44%	28,104,372	-12.02%	65	1.19%	51	-19.05%	21	90.91%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 18, 2025	SEIDENBERG BETH C	-	Buy	$1000.00K
Dec 18, 2025	Westlake BioPartners Opportunity Fund I, L.P.	-	Buy	$1000.00K
Dec 15, 2025	Walker Karen Marie	Chief Technology Officer	Sell	$292.78K
Feb 12, 2024	GILEAD SCIENCES, INC.	-	Buy	$20.02M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	2	1
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

KYTX Ownership FAQ

Who Owns Kyverna Therapeutics?

Kyverna Therapeutics shareholders are primarily institutional investors at 52.17%, followed by 11.88% insiders and 35.95% retail investors. The average institutional ownership in Kyverna Therapeutics's industry, Biotech Stocks , is 45.45%, which Kyverna Therapeutics exceeds.

Who owns the most shares of Kyverna Therapeutics?

Kyverna Therapeutics’s largest shareholders are Vida ventures advisors (4.52M shares, 10.47%), Gilead sciences (4.13M shares, 9.55%), and Bain capital life sciences investors (3.37M shares, 7.79%). Together, they hold 27.80% of Kyverna Therapeutics’s total shares outstanding.

Does Blackrock own Kyverna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kyverna Therapeutics.

Who is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested?

Vida ventures advisors is Kyverna Therapeutics’s biggest shareholder by percentage of total assets invested, with 92.41% of its assets in 4.52M Kyverna Therapeutics shares, valued at 27.14M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools